Taken together, these findings indicate that vascular dysfunction in obesity results in an imbalance between NO vasodilator pathway and ET-1 vasoconstrictor activity towards the latter, where ET-1 contribution to the endothelial function is powerful and is associated with impaired in NO- bioavailability. This evidence concerns the gene EDN1 and obesity disorder.